The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells. Biomedical Research and Therapy, [S. l.], v. 6, n. 4, p. 3131–3140, 2019. DOI: 10.15419/bmrat.v6i4.538. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/538.. Acesso em: 15 nov. 2024.